How Investing in C2 Keep Could Have Prevented $192K in Controlled Substance Violations

In this case, an independently owned pharmacy in Connecticut was fined $192,000 in civil penalties for violations of the Controlled Substances Act. Following a DEA investigation, regulators determined that the pharmacy failed to maintain complete and accurate records of controlled substance activity from early 2022 through mid 2024.

Beyond the financial penalty, the pharmacy was placed under a mandatory three-year Corrective Action Plan designed to enforce ongoing safety and CSA compliance. While enforcement actions like this may seem uncommon, controlled substance violations tied to recordkeeping gaps and documentation errors occur far more frequently than many pharmacy owners realize.

The investigation identified several significant compliance failures that ultimately led to these controlled substance violations. The pharmacy did not complete a required biennial inventory, failed to execute a valid power of attorney, and allowed an unauthorized individual to sign DEA 222 order forms on eight or more occasions. In addition, the pharmacy failed to properly retain essential documentation, including order forms, invoices, and other required records related to controlled substance transactions.

These controlled substance violations were not the result of a single mistake. Instead, they stemmed from fragmented and inefficient compliance workflows. Many pharmacies still rely on manual logbooks, binders, spreadsheets, and filing cabinets to manage controlled substance documentation. When essential data and paperwork are scattered throughout different areas of the pharmacy, mathematical errors, missing files, and inconsistent documentation become difficult to avoid.

As a result, piecing together biennial inventory reports or responding to a DEA request using incomplete and disorganized records can take hours or even days. These outdated workflows also lack defined access controls. Without proper safeguards in place, it becomes increasingly difficult to prevent unauthorized actions, even in otherwise well managed pharmacies. Over time, these weaknesses can escalate into serious controlled substance violations.

On paper, the monetary cost of this case was $192,000. In reality, the total cost of controlled substance violations often extends far beyond the settlement amount.

When factoring in legal fees, staff time spent responding to the investigation, reputational damage within the community, the stress and distraction of a multi month or multiyear federal enforcement process, and the ongoing scrutiny that follows, the consequences can be devastating.

The decision ultimately comes down to this. Invest in compliant systems and structured workflows from the beginning or take shortcuts and accept the risk of costly controlled substance violations.

To strengthen compliance without adding unnecessary complexity, many pharmacies are reengineering their workflows to unify recordkeeping and inventory management. Instead of relying on paper logbooks and spreadsheets, pharmacists are investing in modern compliance solutions that reduce the risk of mathematical errors, missing documentation, and damaged records.

Cloud based systems are becoming a preferred solution because they allow pharmacies to securely manage large volumes of data and organize order documentation in one centralized location. However, high implementation costs and resource requirements often create barriers for smaller and independently owned pharmacies.

That is where C2 Keep provides a clear advantage.

C2 Keep is a comprehensive controlled substance compliance solution designed specifically for pharmacies. It integrates directly with pharmacy management systems and wholesalers to automatically track and reconcile inventory activity, eliminating the need for paper logbooks or spreadsheets.

As a cloud-based platform, C2 Keep enables pharmacies to upload and attach relevant documentation, removing the need for physical filing cabinets, and reducing the risk of misplaced records. By centralizing documentation, C2 Keep significantly reduces the likelihood of recordkeeping related controlled substance violations.

One of the most valuable features of C2 Keep is its ability to generate custom, DEA ready reports in seconds. During an audit or investigation, pharmacy staff can quickly provide auditors with accurate, organized information. This level of preparedness dramatically reduces stress and strengthens compliance confidence.

C2 Keep also includes essential security controls that restrict user permissions, ensuring only authorized individuals can perform certain tasks. Additionally, transactions cannot be deleted or modified without proper documentation and accountability. These safeguards are critical in preventing the types of internal breakdowns that often lead to controlled substance violations.

Today, more than 2,000 pharmacists and staff members rely on the C2 Keep app to simplify compliance, strengthen documentation, and reduce risk. As regulatory scrutiny continues to increase, the importance of investing in a proactive solution like C2 Keep becomes even more apparent.

Spending a few thousand dollars per year on a solution like C2 Keep may initially seem like a significant expense. However, it pales in comparison to the hundreds of thousands of dollars that pharmacies can face fines, legal fees, and operational disruption caused by controlled substance violations.

In many cases, inefficient manual workflows are already costing pharmacies more in labor and administrative time, even without enforcement action. Evaluating your current processes may reveal hidden expenses that far exceed the cost of implementing C2 Keep.

Do you continue relying on fragmented systems and accept the risk of controlled substance violations? Or do you invest in C2 Keep and reimagine your controlled substance compliance workflows with greater efficiency, accountability, and confidence?

For many pharmacy owners, the answer becomes clear when the true cost of non-compliance is fully understood.